These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29587669)

  • 1. Ezrin and E-cadherin expression profile in cervical cytology: a prognostic marker for tumor progression in cervical cancer.
    Zacapala-Gómez AE; Navarro-Tito N; Alarcón-Romero LDC; Ortuño-Pineda C; Illades-Aguiar B; Castañeda-Saucedo E; Ortiz-Ortiz J; Garibay-Cerdenares OL; Jiménez-López MA; Mendoza-Catalán MA
    BMC Cancer; 2018 Mar; 18(1):349. PubMed ID: 29587669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered expression of ezrin, E-Cadherin and β-Catenin in cervical neoplasia.
    Auvinen E; Carpen O; Korpela T; Ronty M; Vaheri A; Tarkkanen J
    Neoplasma; 2013; 60(1):56-61. PubMed ID: 23067217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of ezrin predicts poor prognosis in uterine cervical cancer.
    Kong J; Li Y; Liu S; Jin H; Shang Y; Quan C; Li Y; Lin Z
    BMC Cancer; 2013 Nov; 13():520. PubMed ID: 24182314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ezrin contributes to cervical cancer progression through induction of epithelial-mesenchymal transition.
    Kong J; Di C; Piao J; Sun J; Han L; Chen L; Yan G; Lin Z
    Oncotarget; 2016 Apr; 7(15):19631-42. PubMed ID: 26933912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV-16 E6/E7 promotes cell migration and invasion in cervical cancer via regulating cadherin switch in vitro and in vivo.
    Hu D; Zhou J; Wang F; Shi H; Li Y; Li B
    Arch Gynecol Obstet; 2015 Dec; 292(6):1345-54. PubMed ID: 26093522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter Methylation of Ezrin and its Impact on the Incidence and Prognosis of Cervical Cancer.
    Qin R; Cao L; Wang J; Liu J
    Cell Physiol Biochem; 2018; 50(1):277-287. PubMed ID: 30282070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-risk HPV infection and CIN grade correlates to the expression of c-myc, CD4+, FHIT, E-cadherin, Ki-67, and p16INK4a.
    Samir R; Asplund A; Tot T; Pekar G; Hellberg D
    J Low Genit Tract Dis; 2011 Oct; 15(4):280-6. PubMed ID: 21558960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of Ezrin and E-cadherin in nasopharyngeal carcinoma and its significance].
    Wang L; Gao Y; Tu Q; Hong J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 35(9):969-75. PubMed ID: 20871163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The three most common human papillomavirus oncogenic types and their integration state in Thai women with cervical precancerous lesions and carcinomas.
    Aromseree S; Chaiwongkot A; Ekalaksananan T; Kongyingyoes B; Patarapadungkit N; Pientong C
    J Med Virol; 2014 Nov; 86(11):1911-9. PubMed ID: 25091234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-risk human papillomavirus infection and E6 protein expression in lesions of the uterine cervix.
    Pillai MR; Lakshmi S; Sreekala S; Devi TG; Jayaprakash PG; Rajalakshmi TN; Devi CG; Nair MK; Nair MB
    Pathobiology; 1998; 66(5):240-6. PubMed ID: 9732239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined expression of ezrin and E-cadherin is associated with lymph node metastasis and poor prognosis in breast cancer.
    Yu Z; Sun M; Jin F; Xiao Q; He M; Wu H; Ren J; Zhao L; Zhao H; Yao W; Shan F; Cao Y; Wei M
    Oncol Rep; 2015 Jul; 34(1):165-74. PubMed ID: 25955302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interest of human papillomavirus DNA quantification and genotyping in paired cervical and urine samples to detect cervical lesions.
    Ducancelle A; Legrand MC; Pivert A; Veillon P; Le Guillou-Guillemette H; De Brux MA; Beby-Defaux A; Agius G; Hantz S; Alain S; Catala L; Descamps P; Postec E; Caly H; Charles-Pétillon F; Labrousse F; Lunel F; Payan C
    Arch Gynecol Obstet; 2014 Aug; 290(2):299-308. PubMed ID: 24622934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of cervical human papillomavirus (HPV) infection and squamous intraepithelial lesions (SIL) among a cohort of HIV-infected and uninfected Ghanaian women.
    Obiri-Yeboah D; Akakpo PK; Mutocheluh M; Adjei-Danso E; Allornuvor G; Amoako-Sakyi D; Adu-Sarkodie Y; Mayaud P
    BMC Cancer; 2017 Oct; 17(1):688. PubMed ID: 29037188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of ezrin in human non-small cell lung cancer and its relationship with metastasis and prognosis].
    Chen QY; Yan J; Hu HZ; Chen FY; Song J; Jiang ZY; Jiao DM; Wu YQ
    Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):436-40. PubMed ID: 22967445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotyping for Human Papillomavirus (HPV) 16/18/52/58 Has a Higher Performance than HPV16/18 Genotyping in Triaging Women with Positive High-risk HPV Test in Northern Thailand.
    Khunamornpong S; Settakorn J; Sukpan K; Suprasert P; Srisomboon J; Intaraphet S; Siriaunkgul S
    PLoS One; 2016; 11(6):e0158184. PubMed ID: 27336913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [P16(INK4alpha)/Ki-67 immunocytochemical dual staining for detection of cervical lesions associated to papillomavirus infection].
    Toro de Méndez M; Ferrández Izquierdo A; Llombart-Bosch A
    Invest Clin; 2014 Sep; 55(3):238-48. PubMed ID: 25272523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of low-risk HPV infection for the risk of abnormal cervical cytology/histology in more than 40 000 Danish women.
    Nielsen A; Iftner T; Nørgaard M; Munk C; Junge J; Kjaer SK
    Sex Transm Infect; 2012 Dec; 88(8):627-32. PubMed ID: 22773328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt-11 overexpression promoting the invasion of cervical cancer cells.
    Wei H; Wang N; Zhang Y; Wang S; Pang X; Zhang S
    Tumour Biol; 2016 Sep; 37(9):11789-11798. PubMed ID: 27034261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus prevalence in paired urine and cervical samples in women invited for cervical cancer screening.
    Burroni E; Bonanni P; Sani C; Lastrucci V; Carozzi F; ; Iossa A; Andersson KL; Brandigi L; Di Pierro C; Confortini M; Levi M; Boccalini S; Indiani L; Sala A; Tanini T; Bechini A; Azzari C
    J Med Virol; 2015 Mar; 87(3):508-15. PubMed ID: 25418873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
    Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
    Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.